2024 MCM | Controversies in Lung Cancer: Neoadjuvant vs Adjuvant IO in Early Stage NSCLC
Overview
NA
Target Audience
NA
This material is non‑CME, no credits are available, and a certificate will not be provided upon completion.
Faculty
Luis E. Raez, MD, FACP
Date of Release
May 14th, 2025
-1750785214433.webp&w=3840&q=75)
-1750780084008.webp&w=3840&q=75)